Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6840)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 15, 2025 (publication date) through May 9, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Wen X, Qi LM, Zhao K. Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy. World J Diabetes 2025; 16(1): 100376 [PMID: 39817222 DOI: 10.4239/wjd.v16.i1.100376] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Wen X, Qi LM, Zhao K. Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy. World J Diabetes 2025; 16(1): 100376 [PMID: 39817222 DOI: 10.4239/wjd.v16.i1.100376] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i1/100376.htm |
| Number | Citing Articles |
| 1 |
Saleem Ahmad, Sikander Ali, Asad Ur Rehman, Ikram Ul Haq, Iram Liaqat, Muhammad Nauman Aftab, Tadesse Shume. SCFAs’ pleiotropic role in pathogenesis and salutogenesis: mechanisms in exacerbation and regulation of inflammation and fibrosis from gut to host.
Journal of Medical Microbiology
2026; 75(1) doi: 10.1099/jmm.0.002117
|
| 2 |
Guoliang Zheng, Bao Zhang, Haiyue Yu, Zhiyong Song, Xing Xu, Zhichao Zheng, Kui Zhao, Jian Zhao, Yan Zhao. Therapeutic applications and potential biological barriers of nano-delivery systems in common gastrointestinal disorders: a comprehensive review. Advanced Composites and Hybrid Materials 2025; 8(2) doi: 10.1007/s42114-025-01292-3
|
| 3 |
Xing Chen, Menglin Jiang, Jie Liu, Genyi Zhang. Whole grain component: An innovative whole grain model ingredient to glycemic control in diabetic mice via the function of GLP-1. Food Bioscience 2025; 68: 106549 doi: 10.1016/j.fbio.2025.106549
|
| 4 |
Qiong-Hua Chen, Jing-Yang Zheng, Da-Chun Wang. Asthma and stem cell therapy. World Journal of Stem Cells 2025; 17(2): 103599 doi: 10.4252/wjsc.v17.i2.103599
|
| 5 |
Isa G. RODRIGUES, Jose MORENO-NAVARRETE, José M. FERNÁNDEZ-REAL. Gut microbiota and iron homeostasis: implications for glycemic control. Minerva Medica 2025; 116(4) doi: 10.23736/S0026-4806.25.09706-X
|
| 6 |
Yanan Wang, Xinyi Qian, Lingzhi Chen, Yidan Yong, Mengmeng Wu, Yihao Li, Zaizhong Ni, Lulu Li, Ying Shao, Anhui Chen. Structural characteristics of a polysaccharide isolated from Lactaruis volemus Fr. and its anti-diabetic effects regulated by the modulation of gut microbiota and metabolites. International Journal of Biological Macromolecules 2025; 307: 142294 doi: 10.1016/j.ijbiomac.2025.142294
|
| 7 |
Chi Ching Lee, Hongbing Fan, Apollinaire Tsopmo, Joe M. Regenstein, Tolulope Joshua Ashaolu. Plant-based antioxidant peptides: impact on oxidative stress and gut microbiota. Critical Reviews in Food Science and Nutrition 2025; 65(32): 8006 doi: 10.1080/10408398.2025.2490270
|
| 8 |
Amin Mohsenzadeh, Sahar Pourasgar, Amirali Mohammadi, Mahdis Nazari, Soroush Nematollahi, Yeganeh Karimi, Parisa Firoozbakhsh, Hossein Mohsenzadeh, Kasra Kamali, Reza Elahi. The gut microbiota and cardiovascular disease: Exploring the role of microbial dysbiosis and metabolites in pathogenesis and therapeutics. Life Sciences 2025; 381: 123981 doi: 10.1016/j.lfs.2025.123981
|
| 9 |
Huey Shin Tan, Harvinder Kaur Gilcharan Singh, Vanitha Mariappan, Nor Aini Jamil, Suhaili Naim Mustapa, Snigdha Misra. Short-Term Effects of Nonnutritive Sweetener (Sucralose and Saccharin) Consumption on Glycemic Control and Gut Microbiota in Patients With Type 2 Diabetes: Protocol for a Double-Blind, Randomized, Placebo-Controlled, Crossover Trial. JMIR Research Protocols 2025; 14: e82695 doi: 10.2196/82695
|
| 10 |
Xinwei Jiao, Hongyu Li, Ting Wang, Hongchen Fu, Shiwu Wang, Hong Liu, Lei Wang, Xiuyun Li, Aijun Deng, Zhijie Li. Disruption of the 12-hour ultradian rhythm in ocular surface microbiota of T2DM C57BL/6J mice. Experimental Eye Research 2025; 258: 110472 doi: 10.1016/j.exer.2025.110472
|
| 11 |
Yao-Bin Wang, Zhi-Peng Li, Peng Wang, Rui-Bo Wang, Yu-Hua Ruan, Zhen Shi, Hao-Yu Li, Jin-Ke Sun, Yang Mi, Cheng-Jin Li, Peng-Yuan Zheng, Chang-Jiang Zhang. Iron dysregulation, ferroptosis, and oxidative stress in diabetic osteoporosis: Mechanisms, bone metabolism disruption, and therapeutic strategies. World Journal of Diabetes 2025; 16(6): 106720 doi: 10.4239/wjd.v16.i6.106720
|
| 12 |
Tayyaba Yousaf, Ilyas Ahmad, Zohaib Younas, Mohammad Hamid Hamdard, Zia-ur-Rehman Mashwani. Emerging Plant-Based Nanotechnological Advances and Molecular Insights for Type-2 Diabetes, Diagnosis and Treatments-Recent Trends and Future Prospects. ACS Omega 2025; 10(32): 35310 doi: 10.1021/acsomega.5c01900
|
| 13 |
Sijia Zhu, Yan Qiao, Wenjing He, Yaojie Xiao, Guiqin Song, Kang Liu, Shuguang Fang. Multi‐Strain Probiotics BLa80, LRa05, and BBr60 Modulate Inflammation, Bile Acids, and Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial. Food Science & Nutrition 2026; 14(4) doi: 10.1002/fsn3.71735
|